V. Barış Et Al. , "Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.," Kardiologia polska , vol.79, pp.53-57, 2021
Barış, V. Et Al. 2021. Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.. Kardiologia polska , vol.79 , 53-57.
Barış, V., Dinçsoy, B., Gedikli, E., & Erdemb, A., (2021). Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.. Kardiologia polska , vol.79, 53-57.
Barış, VÖ Et Al. "Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.," Kardiologia polska , vol.79, 53-57, 2021
Barış, VÖ Et Al. "Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.." Kardiologia polska , vol.79, pp.53-57, 2021
Barış, V. Et Al. (2021) . "Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.." Kardiologia polska , vol.79, pp.53-57.
@article{article, author={VÖ Barış Et Al. }, title={Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.}, journal={Kardiologia polska}, year=2021, pages={53-57} }